Article Published 6 Feb 2026 Hospitals: Prepare Now For Mandatory Provider-Based Attestation Process United States Food, Drugs, Healthcare, Life Sciences SR McDermott Will & Schulte
Article Published 5 Feb 2026 Congress Probes Chinese Biotech GLP-1 Product Compliance United States Food, Drugs, Healthcare, Life Sciences KM Katten Muchin Rosenman LLP
Article Published 5 Feb 2026 Of Drugs And DTC Platforms: American Consumerism, TrumpRx, Telehealth, And The Specter Of Congressional Intervention United States Food, Drugs, Healthcare, Life Sciences SM Sheppard
Article Published 5 Feb 2026 NSCEB Paper Outlines Policy Options To Modernize Oversight Of Biotechnology Products United States Food, Drugs, Healthcare, Life Sciences BC Bergeson & Campbell
Article Published 5 Feb 2026 FDA Clinical Decision Support Software Guidance Refresh : Clearer Rules, Broader Innovation United States Food, Drugs, Healthcare, Life Sciences KM Katten Muchin Rosenman LLP
Article Published 5 Feb 2026 FDA's Draft Guidance For Cosmetics Industry Explains Records-Access Authority During Inspections United States Food, Drugs, Healthcare, Life Sciences WR Wiley Rein
Article Published 4 Feb 2026 District Court Certifies 23(b)(3) Class Action Alleging Injury From Misrepresentations That Pet Food Was "Healthy" Despite Presence Of PFAS United States Food, Drugs, Healthcare, Life Sciences MG Manko, Gold, Katcher & Fox
Article Published 4 Feb 2026 Health Headlines: January 2026 United States Food, Drugs, Healthcare, Life Sciences GP Goodwin Procter LLP
Article Published 4 Feb 2026 FDA Seeks To Delay PFAS Litigation And Issues Report On PFAS In Cosmetics United States Food, Drugs, Healthcare, Life Sciences D Dechert
Article Published 4 Feb 2026 DOL Proposes Sweeping New Disclosure Rules For Pharmacy Benefit Managers United States Employment and HR FL Foley & Lardner
Article Published 4 Feb 2026 OIG Issues Special Advisory Bulletin On DTC Prescription Drug Sales To Federal Health Care Program Enrollees United States Food, Drugs, Healthcare, Life Sciences AF ArentFox Schiff
Article Published 4 Feb 2026 FDA Issues Report On PFAS In Cosmetics: Key Findings, Risks, And Regulatory Implications United States Food, Drugs, Healthcare, Life Sciences AF ArentFox Schiff
Article Published 4 Feb 2026 Preventative Care Test Garners Commercial Cost-Sharing Waiver Flexibility From OIG United States Food, Drugs, Healthcare, Life Sciences BB Bass, Berry & Sims
Article Published 4 Feb 2026 Food Venture Financing News – Weekly Issue No. 269 United States Corporate/Commercial Law DW Davis Wright Tremaine
Article Published 4 Feb 2026 DOL Proposes Pharmacy Benefit Manager Fee Disclosure Rule United States Employment and HR GL Groom Law Group
Article Published 3 Feb 2026 3 Challenges And Opportunities For The Restaurant Industry In 2026 United States Food, Drugs, Healthcare, Life Sciences GG Greenberg Glusker Fields Claman & Machtinger
Article Published 3 Feb 2026 From The Locked Medicine Cabinet To Locker Rooms: The Sports Playbook For Medication Compliance; Assessing The Risks And Realities United States Food, Drugs, Healthcare, Life Sciences KM Katten Muchin Rosenman LLP
Article Published 3 Feb 2026 DEA Extends Telemedicine Flexibilities For Controlled Substance Prescribing For 2026 United States Food, Drugs, Healthcare, Life Sciences SR McDermott Will & Schulte
Article Published 2 Feb 2026 Heads Up, Liquor Licensees: Kratom And 7-OH Could Put Your License At Risk United States Food, Drugs, Healthcare, Life Sciences N Nossaman LLP
Article Published 2 Feb 2026 DOJ Enforcement Branch Signals Strategic Shift In Civil Consumer And Policy Litigation United States Consumer Protection MS Miller Shah